| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 2.860 | 20130605, Simon D
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 0.000 | 20120528, Patelis A
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 0.900 | 20130912, Lacerda Araujo LM
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 4.290 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 0.000 | 20091005, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 11.400 | 20140331, Rockmann H
| | 1.8 - Fruit Allergy | 2012 | Spain | IgE | 212 | 21.000 | 20120912, Palacin A
| | 1.9 - Pollen Allergy | 2012 | Spain | IgE | 117 | 7.000 | 20120912, Palacin A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 198 | 5.050 | 20101118, Bublin M
| | 3.2.1 - Source Sensitized (IgE) | 2013 | Italy | IgE | 284 | 39.440 | 20130420, Palazzo P
| | 3.2.1 - Source Sensitized (IgE) | 2011 | Italy | IgE | 835 | 40.000 | 20110211, DAvino R
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 0.000 | 20111214, Zheng YW
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 4.550 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 15.000 | 20091121, Ebo DG
| | 4.1.6 - Heterologous Source Sensitized (High IgE) | 2011 | Austria | IgE | 60 | 3.330 | 20110211, DAvino R
| | 4.1.6 - Heterologous Source Sensitized (High IgE) | 2011 | Italy | IgE | 214 | 9.810 | 20110211, DAvino R
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 2.700 | 20090826, Ebo DG
| | 5.1.1 - Source Exposed (Symptoms) | 2004 | Austria | IgE | 31 | 87.100 | 20041113, Bublin M
| | 5.1.1 - Source Exposed (Symptoms) | 2012 | Bulgaria / Czech Republic / Lithuania / Poland | IgE | 56 | 18.000 | 20121112, Le TM
| | 5.1.1 - Source Exposed (Symptoms) | 2012 | France / Italy / Netherlands / Switzerland / United Kingdom | IgE | 181 | 11.000 | 20121112, Le TM
| | 5.1.1 - Source Exposed (Symptoms) | 2012 | Greece / Spain | IgE | 45 | 16.000 | 20121112, Le TM
| | 5.1.1 - Source Exposed (Symptoms) | 2012 | Iceland | IgE | 29 | 32.000 | 20121112, Le TM
| | 5.1.1 - Source Exposed (Symptoms) | 2004 | Italy | IgE | 34 | 47.100 | 20041113, Bublin M
| | 5.1.1 - Source Exposed (Symptoms) | 2004 | Netherlands | IgE | 10 | 80.000 | 20041113, Bublin M
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2013 | Italy | IgE | 49 | 8.160 | 20130420, Palazzo P
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2008 | Spain | IgE | 92 | 59.780 | 20080119, Palacin A
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2013 | Italy | IgE (IB) | 49 | 81.630 | 20130420, Palazzo P
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2008 | Spain | SPT | 25 | 72.000 | 20080119, Palacin A
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 8.080 | 20110223, De Knop KJ
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Italy | IgE | 36 | 19.440 | 20130420, Palazzo P
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy | IgE | 11 | 54.540 | 20100909, Bernardi ML
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 237 | 28.270 | 20101118, Bublin M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Switzerland | IgE | 30 | 20.000 | 20100111, Bublin M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2007 | United Kingdom | IgE | 20 | 0.000 | 20070720, Lucas JS
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Italy | SPT | 36 | 36.110 | 20130420, Palazzo P
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.000 | 20120528, Patelis A
|
|
Loading...
Act d 1
